Coming soon! A new version of our stakeholder relations management tool!

The Art and Science of Stakeholder Relations

External engagement by the pharma, biopharma and medical device industry has evolved away from the traditional tactical approach of Key Opinion Leader (KOL) activities towards a more holistic and strategic ‘stakeholder relationship management’ approach. Fishawack pioneers this field through the unique insights of an experienced in-house team of internationally recognised stakeholder relations professionals from within the pharma industry. Click here to meet the team!

Stakeholder relations strategic planning and engagement is central to the commercial success of any brand in a constantly changing environment. Understanding your strategic stakeholder relations business needs, internally and externally, and creating and executing a well thought out business plan is central to the expertise of the Fishawack team. Find out more about what makes our approach different here!

Did you know that we offer both internal stakeholder relations specialist training (including workshops), and also digital tools for effective and compliant stakeholder relationship management? See our download/information area for more details!

Resources

New stakeholder relations division at Fishawack Group April 2011 Click here to request details of our stakeholder relations training programmes and workshops. Click here to request details of our stakeholder relations software Click here to request any other information

There is an unfulfilled need for a standardised approach to managing these important stakeholder relationships, and we’re excited to be able to pioneer these services through the unique insight of our experienced industry professionals and in-house experts.

Oliver Dennis, Fishawack CEO

Pharmaceutical companies urgently need to remodel their organization, objectives and tactics if they are to survive in this highly competitive and regulated environment.

First Word Dossier; KOL Management – The New Rules, January. 2010

The industry has identified key opinion leaders (KOLs) as its best allies. KOLs can provide the industry with expert guidance on a wide spectrum of critical issues ranging from choosing the right product, which is both innovative and appealing to the market, to attaining a greater share of the market.

First Word Dossier; KOL Management – The New Rules, January. 2010

Pharmaceutical companies need to initiate appropriate KOL programs as part of the overall strategy.

First Word Dossier; KOL Management – The New Rules, January. 2010